Key facts
- Clarion (Enterprise Systems (Healthcare))’s last known valuation is $7.1M (Jan 2024).
- It has raised $5.8M; the latest was Early Stage VC in Feb 2025.
- Notable investors include Y Combinator, Sequoia Capital, Accel, Unpopular Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Clarion (Enterprise Systems (Healthcare))
- ·The full record, as it builds
Funding rounds
No funding rounds for Clarion (Enterprise Systems (Healthcare)) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Clarion (Enterprise Systems (Healthcare))
Developer of an AI-powered communication platform designed to automate routine patient interactions and improve clinic efficiency. The company's platform offers multichannel AI agents, workflow integration with clinical systems, and customizable patient-facing communication, enabling healthcare providers, outpatient clinics, and virtual care organizations to reduce staff burden, enhance patient access, and deliver timely care.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2024
- Employees
- 6
- Website
- clarionhealth.com/
- Ownership
- Privately Held (backing)
Clarion (Enterprise Systems (Healthcare)) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Clarion (Enterprise Systems (Healthcare)) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Clarion (Enterprise Systems (Healthcare)) in its N-PORT filings yet. We sweep new filings monthly.